Table 2.
Eurotransplant Heart Allocation System Tiers
| International High Urgency Status |
| ● Inotrope dependency |
| ○ Meeting following 3 criteria for cardiac hypoperfusion syndrome |
| ■ Signs and symptoms of terminal heart failure |
| ■ Hemodynamic features |
| ● Cardiac index < 2.0 L/min/m2 |
| ● Mixed venous saturation < 50% |
| ● Pulmonary capillary wedge pressure > 15 mm Hg |
| ■ Secondary organ damage (at least one of the following) |
| ● Lactate above normal |
| ● Bilirubin above normal |
| ● Calculated GFR < 60 ml/min |
| ● Serum sodium < 135 mmol/L |
| ○ Meeting one of the following 2 criteria for inotrope dependency |
| ■ When on continuous inotrope infusion with Dobutamine, Milrinone, or Enoximone for at least 72 hours |
| ● Cardiac index stays < 2.0 L/min/m2 OR |
| ● There is proof of decrease in cardiac index below 2.0 L/min/m2 when inotrope is weaned |
| ■ Cardiac hypoperfusion syndrome within 14 days of a single infusion of Levosimendan |
| ● Complications while on assist device |
| ○ Assist device complication requiring device exchange OR |
| ○ Infection on assist device with positive cultures or other proof (driveline infection excluded) OR |
| ○ Repeated assist device related cerebral events demonstrated by CT scan |
| ● Additional Special Cases |
| ○ Primary graft failure within 1 week after transplant |
| National High Urgency Status |
| ● Granted according to national policies |
| Normal Urgency Status |
| ● Stable assist device or total artificial heart patients |
| ● Stable heart failure patients not meeting urgency status criteria |